7780 DaYen Biomedical
DaYen Biomedical announced the completion of its share buyback program, acquiring 4.46 million shares for approximately 82.41 million TWD, citing market conditions for not reaching the full target.
📋 Article Processing Timeline
- 📰 Published: May 26, 2026 at 06:31
- 🔍 Collected: May 26, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 31, 2026 at 20:17 (133h 45m after Collected)
DaYen Biomedical announced the completion of its share buyback period on May 25, 2026. The company repurchased 4.46 million shares for a total of 82,408,946 TWD, with an average price of 18.48 TWD per share. While the original target of 7.5 million shares was not met, the company stated that it adopted a phased buyback strategy to account for market price fluctuations and trading volume, aiming to protect shareholder interests.
FAQ
What does a share buyback mean for shareholders?
It generally contributes to supporting the stock price and improving EPS.